{
  "HL7 Standard": {
    "summary": "This FHIR Implementation Guide focuses on standardizing the representation of In Vitro Diagnostic (IVD) test codes and result values using FHIR R4, LOINC, and SNOMED CT. It defines a publication format for IVD manufacturers to share suggested mappings, facilitating consistent adoption by laboratories. The IG heavily relies on FHIR resources and profiles, with no mention or use of HL7 v2, v3, or CDA.",
    "scores": {
      "CDA": 0,
      "Cross-Paradigm": 0.2,
      "FHIR": 1,
      "v2": 0,
      "v3": 0
    }
  },
  "Geographic Scope": {
    "summary": "The Implementation Guide focuses on standardizing IVD test and result value mappings using LOINC and SNOMED CT, primarily targeting the U.S. (FDA, ONC, CDC) but also acknowledging international relevance. While it mentions an `ext-region` extension, it doesn't specify any particular region other than the U.S. Therefore, it's considered a national guide with a strong focus on the U.S.",
    "scores": {
      "Universal Realm": 0.4,
      "National > United States": 0.8,
      "Regional": 0
    }
  },
  "Domain Focus": {
    "summary": "This FHIR Implementation Guide focuses on standardizing the representation of In Vitro Diagnostic (IVD) test codes and result values using LOINC and SNOMED CT. It defines a publication format for IVD manufacturers to share suggested mappings, primarily impacting the diagnostics domain. While it touches upon administrative aspects through device and organization identification, its core purpose is to improve the consistency and interoperability of diagnostic data.",
    "scores": {
      "Administrative": 0.4,
      "Care Planning": 0,
      "Clinical Data": 0.6,
      "Clinical Knowledge": 0.2,
      "Diagnostics": 1,
      "Identity & Security": 0.2,
      "Medications": 0,
      "Payment & Financial": 0,
      "Public Health": 0.4,
      "Quality & Reporting": 0.2,
      "Research": 0.2,
      "Workflow": 0.6
    }
  },
  "Implementation Approach": {
    "summary": "This FHIR Implementation Guide focuses on defining a standardized format for publishing IVD test and result value mappings to LOINC and SNOMED CT using FHIR R4. It heavily relies on Data Profiles and Terminology to achieve its goal. While REST APIs are mentioned as a potential publication method, they are not the primary focus. Other aspects like Decision Support, Documents, Forms & UI, Messaging, Services, and Subscriptions are not utilized in this IG.",
    "scores": {
      "Data Profiles": 1,
      "Decision Support": 0,
      "Documents": 0,
      "Forms & UI": 0,
      "Messaging": 0,
      "REST APIs": 0.4,
      "Services": 0,
      "Subscriptions": 0,
      "Terminology": 0.8
    }
  },
  "Implementers": {
    "summary": "This FHIR Implementation Guide focuses on standardizing the mapping of In Vitro Diagnostic (IVD) test codes and result values to LOINC and SNOMED CT. Therefore, Lab Systems are the primary implementers, with EHRs and Clinical Decision Support systems playing important supporting roles. Other systems have limited or no involvement.",
    "scores": {
      "EHR Systems": 0.6,
      "PHR Systems": 0,
      "Payer Systems": 0,
      "Pharmacy Systems": 0,
      "Lab Systems": 1,
      "Imaging Systems": 0,
      "Public Health Systems": 0.2,
      "Clinical Decision Support": 0.8,
      "Research Platforms": 0.4
    }
  },
  "Users & Stakeholders": {
    "summary": "This FHIR Implementation Guide (IG) focuses on standardizing the mapping of In Vitro Diagnostic (IVD) test codes and result values to LOINC and SNOMED CT. Therefore, the primary users are IVD manufacturers who create and publish these mappings and laboratory personnel who consume them to configure their Laboratory Information Systems (LIS). Other stakeholders, like LIS vendors and terminology providers, also play significant roles. Clinical care teams benefit indirectly from improved data standardization, while public health agencies and research organizations can leverage the standardized data for population health monitoring and research. Payers and government agencies have a less direct involvement.",
    "scores": {
      "Clinical Care Teams": 0.4,
      "Healthcare Administrators": 0.2,
      "Patients and Caregivers": 0,
      "Payers": 0,
      "Public Health Agencies": 0.6,
      "Research Organizations": 0.6,
      "Government Agencies": 0.4
    }
  },
  "meta": {
    "model": "gemini-exp-1206",
    "generation_config": {
      "temperature": 0
    },
    "workerCount": 3
  }
}